指南与共识间质性肺疾病

CVID相关肉芽肿性淋巴细胞性间质性肺病诊断指南

Clinical practice guideline for the diagnosis of granulomatous-lymphocytic interstitial lung disease in patients with common variable immunodeficiency disorders: an ERS Clinical Research Collaboration
RSS 订阅 · 指南共识 · 间质性肺病 · 2026-06-25

欧洲呼吸学会(ERS)临床研究协作组针对常见变异型免疫缺陷病(CVID)患者中肉芽肿性淋巴细胞性间质性肺病(GLILD)的筛查与诊断制定临床实践指南。专家组采用GRADE方法评估证据,并通过证据-决策框架确定推荐方向与强度。指南建议对所有成人CVID患者筛查GLILD,首选高分辨率CT,并由多学科团队评估;因证据确定性低,多数推荐为条件性推荐。

要点

  • 所有成人CVID患者均应筛查GLILD,首选高分辨率CT。
  • GLILD诊断评估应由多学科团队完成,常规肺活检非必需。
  • 诊断中需排除肺部感染,并以支气管肺泡灌洗寻找淋巴细胞性肺泡炎。

核心结论

  • 指南为CVID患者GLILD的诊断提供国际统一的循证与共识推荐,以提高各中心间可比性、医疗公平性并促进多中心研究。

研究设计与样本

  • ERS临床研究协作组召集多学科专家组与方法学家,确定临床问题优先级,采用GRADE方法评价证据,并用证据-决策框架决定推荐方向与强度。

主要发现

  • 多数推荐因健康效应相关证据确定性低而被定为条件性推荐。
  • 推荐所有成人CVID患者筛查GLILD,首选高分辨率CT。
  • 评估应由多学科团队进行;常规肺活检非强制,但非典型表现时有必要。
  • 诊断过程应排除肺部感染,并通过支气管肺泡灌洗寻找淋巴细胞性肺泡炎。
  • 肺功能受损严重程度应通过含气体弥散评估的肺功能检查评价。

关键数值与推荐

  • 筛查对象:所有成人CVID患者;首选检查:高分辨率计算机断层扫描。
  • 常规肺活检非必需,非典型表现时需进行。
  • 采用支气管肺泡灌洗寻找淋巴细胞性肺泡炎,并排除肺部感染。
  • 肺功能检查应包含气体弥散评估。
  • 多数推荐为条件性推荐,依据为证据确定性低。

临床怎么用

  • 对成人CVID患者常规以高分辨率CT筛查GLILD,异常者转多学科团队评估。
  • 诊断时先排除肺部感染,必要时行支气管肺泡灌洗寻找淋巴细胞性肺泡炎。
  • 肺功能评估应包含气体弥散,非典型表现者考虑肺活检。

局限性

  • 多数推荐为条件性推荐,依据为健康效应相关证据确定性低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Eur Respir J. 2026 Sep 25;68(3):2502224. doi: 10.1183/13993003.02224-2025. Print 2026 Sep. ABSTRACT BACKGROUND: Granulomatous-lymphocytic interstitial lung disease (GLILD) is a lung disease first described in people affected by common variable immunodeficiency disorders (CVID). Despite growing recognition of GLILD, there is no accepted diagnostic and management guideline, and current practice varies significantly across centres and countries. This clinical practice guideline provides evidence- and consensus-based recommendations on the screening and diagnosis of GLILD in patients with CVID. METHODS: A panel representing multiple interdisciplinary perspectives convened with methodologists to prioritise clinical questions, and review and assess the evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Evidence-to-decision frameworks were used to decide on the direction and strength of recommendations. RESULTS: Screening for GLILD is recommended in all adult patients with CVID, preferably using high-resolution computed tomography. Evaluation should be performed by a multidisciplinary team. Routine lung biopsies are not mandatory but necessary for atypical presentations. As part of the diagnostic process, pulmonary infections should be excluded and lymphocytic alveolitis sought for by means of bronchoalveolar lavage. The severity of lung function impairment should be evaluated using pulmonary function tests including gas transfer assessment. Most of the recommendations are graded as conditional because of low certainty in the evidence regarding health effects. CONCLUSIONS: This guideline allows for international homogeneity in the diagnosis of GLILD, thereby paving the way for improved comparability between centres, improving equity in healthcare for those affected by GLILD and facilitating multicentre research collaborations for future studies. PMID: 42350065 | PMC: PMC13612986 | DOI: 10.1183/13993003.02224-2025

来源:指南共识 · 间质性肺病,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 间质性肺病:Clinical practice guideline for the diagnosis of granulomatous-lymphocytic interstitial lung disease in patients with common variable immunodeficiency disorders: an ERS Clinical Research Collaboration

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。